Veraxa Biotech (VRXA) director adds 50K shares in open-market buy

Rhea-AI Filing Summary

Veraxa Biotech AG (VRXA) director Oliver Rolf Baumann reported an indirect open-market purchase of Veraxa ordinary shares. On 2026-08-27, an entity associated with him, Akira Holding AG, purchased 50,000 Ordinary Shares at $1.50 per share. Following this transaction, Akira Holding AG holds 5,773,618 Veraxa ordinary shares that Baumann may be deemed to beneficially own.

Insider Trade Summary

Net Buyer: 50,000 shares

Net Buy 1 txn

Insider Baumann Oliver Rolf

Role Director

Bought 50,000 shs ($75K)

Type	Security	Shares	Price	Value
Purchase	Ordinary Shares F1	50,000	$1.50	$75K

Holdings After Transaction: Ordinary Shares — 5,773,618 shares (Indirect, See Footnote)

Footnotes (1)

1. F1. The reported securities are held by Akira Holding AG. The reporting person may be deemed to beneficially own such securities by virtue of their relationship with Akira Holding AG.

Key Figures

Ordinary Shares purchased: 50,000 shares Purchase price per share: $1.50 per share Shares held after transaction: 5,773,618 shares +1 more

4 metrics

Ordinary Shares purchased 50,000 shares Non-derivative purchase on 2026-08-27

Purchase price per share $1.50 per share Ordinary Shares transaction on 2026-08-27

Shares held after transaction 5,773,618 shares Indirectly held by Akira Holding AG following the purchase

Net buy shares reported 50,000 shares Net-buy across all reported transactions in this Form 4

Key Terms

Ordinary Shares, indirect, beneficially own

3 terms

Ordinary Shares financial

"security_title: "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

indirect financial

"ownership_type: "indirect""

beneficially own financial

"may be deemed to beneficially own such securities"

Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.

FAQ

What insider transaction did VRXA director Oliver Rolf Baumann report?

He reported an indirect purchase of 50,000 Ordinary Shares of Veraxa Biotech AG at $1.50 per share on 2026-08-27, held through Akira Holding AG.

How many VRXA shares were bought in this Form 4 filing?

The filing shows a purchase of 50,000 Ordinary Shares of Veraxa Biotech AG in a single reported transaction on 2026-08-27.

What was the purchase price per VRXA share in the reported transaction?

The reported purchase price was $1.50 per share for the 50,000 Ordinary Shares acquired on 2026-08-27.

How many VRXA shares does Akira Holding AG hold after this transaction?

After the transaction, Akira Holding AG holds 5,773,618 Ordinary Shares of Veraxa Biotech AG, which Baumann may be deemed to beneficially own.

Is the VRXA share ownership reported as direct or indirect for Oliver Rolf Baumann?

The 5,773,618 Ordinary Shares are reported as indirectly owned, as they are held by Akira Holding AG, with Baumann potentially deemed a beneficial owner through his relationship to that entity.

Was the VRXA trade made under a Rule 10b5-1 trading plan?

The document-level 10b5-1 indicator is false, so the transaction is not represented as being effected pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/31/2026 - 04:11 PM Accepted by SEC EDGAR 08/31/2026 - 04:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Baumann Oliver Rolf

(Last) (First) (Middle)

TALACKER 35

(Street)

ZURICH V8 8001

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Veraxa Biotech AG - Post de-SPAC [ VRXA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/27/2026		P		50,000	A	$1.5	5,773,618	I(1)	See Footnote(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported securities are held by Akira Holding AG. The reporting person may be deemed to beneficially own such securities by virtue of their relationship with Akira Holding AG.

	/s/ Oliver Baumann	08/31/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)